TG Therapeutics to Host Conference Call on Third Quarter 2026 Financial Results and Business Update
Business Wire•02/11/2026•07:30 ET
0
Key Highlights
- ➤TG Therapeutics schedules November 9 call for Q3 2026 results and outlook
- ➤Financial results will be released before the conference call
- ➤Michael S. Weiss will host the business update call
- ➤BRIUMVI remains approved for relapsing multiple sclerosis in the U.S. and abroad
TG Therapeutics to Host Conference Call on Third Quarter 2026 Financial Results and Business Update
CONFERENCE CALL TO BE HELD MONDAY, NOVEMBER 9, 2026, AT 8:30 AM ET
Get started
Create a free account to read the full story.